Takeda Pharmaceutical Co. Ltd.

TAK·NYSE·$15.87Share Price as of 11/2·$50BMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)06/17/26 20-FAnnual report (foreign)06/25/25 20-FAnnual report (foreign)06/26/24 20-FAnnual report (foreign)06/28/23 20-FAnnual report (foreign)06/29/22

Disclosures

6-KForeign issuer report10/29/26 6-KForeign issuer report10/29/26 6-KForeign issuer report09/14/26 6-KForeign issuer report08/31/26 6-KForeign issuer report08/06/26

Prospectuses and Registrations

424B2Prospectus for primary offering06/27/25 FWPFree writing prospectus06/27/25 424B5Prospectus supplement06/26/25 F-3ASRProspectus / registration06/25/25 424B2Prospectus for primary offering06/28/24

Proxies

No matching filings.

Ownership

144Proposed sale of securities10/30/26 144Proposed sale of securities10/30/26 Form 4Insider transaction09/15/26 144Proposed sale of securities09/10/26 Form 4Insider transaction09/03/26

Other

IRANNOTICEIran disclosure06/17/26 SDConflict Minerals disclosure05/22/26 N-PXAnnual report of proxy voting record08/21/25 SDConflict Minerals disclosure05/12/25 SDConflict Minerals disclosure04/25/24